Alvotech (ALVO) reporting calendar
Alvotech files periodic reports with the SEC as ALVO on Nasdaq. Atlas tracks 5 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 26 Aug 2026 – 16 Nov 2026
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 31 Mar 2026
- Reports on record
- 5
How this window is derived. Derived from this issuer's own filing history: 2 periods at a median 199-day cadence, filed a median 80 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open ALVO market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001898416-26-000004 |
| 20-F | 31 Dec 2024 | 27 Mar 2025 | 86 days | 0001628280-25-015052 |
| 20-F | 31 Dec 2023 | 20 Mar 2024 | 80 days | 0001628280-24-012230 |
| 20-F | 31 Dec 2022 | 1 Mar 2023 | 60 days | 0001193125-23-056506 |
| 20-F | 15 Jun 2022 | 22 Jun 2022 | 7 days | 0001193125-22-178843 |
Source: SEC EDGAR company submissions for CIK 0001898416. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.